Archives

Tesfa

Extensive scientific background in immunology and infectious disease, having worked with T-cells in the context of mycobacterial infection

Whittaker

Gary Whittaker

The structure and function of viral envelope proteins, how genomic mutations lead to changes in the envelope proteins and control viral pathogenesis in influenza viruses and coronaviruses,SARS-CoV, MERS-CoV and feline coronaviruses; novel vaccines and ...
Read More

Rhee

Kyu Rhee

We are interested in the chemical biology of metabolism as a mediator of the host-pathogen interaction. We focus specifically on Mycobacterium tuberculosis and its ability to both asymptomatically infect and cause disease in humans.

Rudd

Brian Rudd

My lab is focused on understanding basic principles of immunity against infection and age-related changes that alter immune responses in early life. We also are interested in determining how environmental factors (maternal diet, microbiome, ...
Read More

Mehta

Saurabh Mehta

Given that a) the majority of the world is either over- or under-nourished; and b) diet and nutrition-related factors represent the largest proportion of risk factors for global mortality and morbidity, we often use ...
Read More

Nixon

Douglas Nixon

I am interested in host pathogen interactions in human retrovirus infections, including HIV-1 and human endogenous retroviruses.

Parrish

Colin Parrish

We study viruses of animals, focusing on those that have jumped from one host to another. The main subjects of study include the canine parvovirus, which emerged in 1978 to cause a pandemic in ...
Read More

Guarino

Dr. Guarino is interested in the development of novel serologic assays for the diagnosis of infection with viral and bacterial pathogens in companion and production animals. Of particular interest is the diagnosis of commonly ...
Read More

Brito

Ilana Brito

My lab focuses on the mechanisms that underlie microbiome-associated disorders. We apply systems biology and precision engineering to develop microbiome-base diagnostics and therapeutics.